Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study

The Lancet Infectious Diseases

Volumn 17, Issue 4, 2017, Pages 400-410

  Quan, Jingjing ^a   Li, Xi ^c   Chen, Yan ^a   Jiang, Yan ^a   Zhou, Zhihui ^a   Zhang, Huichuan ^a   Sun, Lu ^a   Ruan, Zhi ^a   Feng, Ye ^b   Akova, Murat ^d   Yu, Yunsong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN; SULBACTAM; TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BROTH DILUTION; CHINA; CLINICAL ASSESSMENT; CLINICAL OUTCOME; CONTROLLED STUDY; ELECTROPORATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MORTALITY; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHINA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PREVALENCE;

EID: 85010928639     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30528-X     Document Type: Article

References (32)

1. 1 Olaitan, AO, Morand, S, Rolain, JM, Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol, 5, 2014, 643.
2. 2 Falagas, ME, Rafailidis, PI, Matthaiou, DK, Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat 13 (2010), 132–138.
3. 3 Halaby, T, Al Naiemi, N, Kluytmans, J, van der Palen, J, Vandenbroucke-Grauls, CM, Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother 57 (2013), 3224–3229.
4. 4 Ah, YM, Kim, AJ, Lee, JY, Colistin resistance in Klebsiella pneumoniae. Int J Antimicrob Agents 44 (2014), 8–15.
5. 5 Liu, YY, Wang, Y, Walsh, TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16 (2016), 161–168.
6. 6 Xavier, BB, Lammens, C, Ruhal, R, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill, 21, 2016 PII=30280.
7. 7 Hasman, H, Hammerum, AM, Hansen, F, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill, 20, 2015 pii=30085.
8. 8 Fraenkel-Wandel, Y, Raveh-Brawer, D, Wiener-Well, Y, et al. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother 71 (2016), 1083–1087.
9. 9 Girometti, N, Lewis, RE, Giannella, M, et al. Klebsiella pneumoniae bloodstream infection: epidemiology and impact of inappropriate empirical therapy. Medicine (Baltimore) 93 (2014), 298–309.
10. 10 Falagas, ME, Karageorgopoulos, DE, Nordmann, P, Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol 6 (2011), 653–666.
11. 11 Quan, J, Zhao, D, Liu, L, et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother, 2016, 10.1093/jac/dkw372 published online Sept 13.
12. 12 Chow, JW, Yu, VL, Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 11 (1999), 7–12.
13. 13 Doi, Y, Park, YS, Rivera, JI, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis 56 (2013), 641–648.
14. 14 Rodriguez-Bano, J, Picon, E, Gijon, P, et al. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50 (2010), 40–48.
15. 15 Gutierrez-Gutierrez, B, Perez-Galera, S, Salamanca, E, et al. A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae. Antimicrob Agents Chemother 60 (2016), 4159–4169.
16. 16 Carmeli, Y, Armstrong, J, Laud, PJ, et al. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. Lancet Infect Dis 16 (2016), 661–673.
17. 17 Jayol, A, Poirel, L, Brink, A, Villegas, MV, Yilmaz, M, Nordmann, P, Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 58 (2014), 4762–4766.
18. 18 Cannatelli, A, D'Andrea, MM, Giani, T, et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 57 (2013), 5521–5526.
19. 19 Sullivan, MJ, Petty, NK, Beatson, SA, Easyfig: a genome comparison visualizer. Bioinformatics 27 (2011), 1009–1010.
20. 20 Brauer, A, Telling, K, Laht, M, et al. Plasmid with colistin resistance gene mcr-1 in ESBL-producing Escherichia coli strains isolated from pig slurry in Estonia. Antimicrob Agents Chemother, 2016, 10.1128/AAC.00443-16 published online Aug 29.
21. 21 Jamal, WY, Albert, MJ, Rotimi, VO, High prevalence of New Delhi metallo-beta-lactamase-1 (ndm-1) producers among carbapenem-resistant enterobacteriaceae in Kuwait. PLoS ONE, 11, 2016, e0152638.
22. 22 Jean, SS, Lee, WS, Yu, KW, et al. Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). J Microbiol Immunol Infect 49 (2016), 969–976.
23. 23 Haenni, M, Poirel, L, Kieffer, N, et al. Co-occurrence of extended spectrum beta lactamase and MCR-1 encoding genes on plasmids. Lancet Infect Dis 16 (2016), 281–282.
24. 24 Falgenhauer, L, Waezsada, SE, Yao, Y, et al. Colistin resistance gene mcr-1 in extended-spectrum beta-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect Dis 16 (2016), 282–283.
25. 25 Hao, H, Cheng, G, Iqbal, Z, et al. Benefits and risks of antimicrobial use in food-producing animals. Front Microbiol, 5, 2014, 288.
26. 26 Nordmann, P, Poirel, L, Plasmid-mediated colistin resistance: an additional antibiotic resistance menace. Clin Microbiol Infect 22 (2016), 398–400.
27. 27 Nicolas-Chanoine, MH, Bertrand, X, Madec, JY, Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27 (2014), 543–574.
28. 28 Mulvey, MR, Mataseje, LF, Robertson, J, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16 (2016), 289–290.
29. 29 Chinese, XDRCWG, Guan, X, He, L, et al. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement. Clin Microbiol Infect 22:suppl 1 (2016), S15–S25.
30. NDM-5 , causing a complicated urinary tract infection in a patient from the United States. MBio 7 (2016), e01191–e01216.
31. 31 Schwarz, S, Johnson, AP, Transferable resistance to colistin: a new but old threat. J Antimicrob Chemother 71 (2016), 2066–2070.
32. 32 Sun, J, Yang, RS, Zhang, Q, et al. Co-transfer of blaNDM-5 and mcr-1 by an IncX3-X4 hybrid plasmid in Escherichia coli. Nat Microbiol, 1, 2016, 16176.